AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)

RecruitingNAAges 18 Years - anyAllSociety of Interventional Oncology
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

To demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of โ‰ค 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patient must be at least 18 years old. 2. Patient has signed a written informed consent for the MWA and participation in the study. 3. Patient with pathologically confirmed CRC with hepatic metastases confirmed on imaging (e.g., CT or MRI). 4. Patient has up to 3 hepatic metastases, each up to 2.5 cm in largest diameter. 5. Patient may have up to 5 lesions in the lung (none larger than โ‰ฅ 2.0 cm) and/or any lymph node โ‰ค2.0 cm in the largest diameter 6. Ability to safely create an ablation zone (AZ) that completely covers the tumor with minimal margin of 5.0 mm. Subcapsular (any tumor within 10 mm from the liver capsule) or perivascular (any tumor within 10 mm from a vessel larger than 3 mm) lesions may be included. For these tumors, the calculation of the margin will not apply to the area abutting the capsule or the vessel. 7. The target tumor(s) is/are visible by US and/or CT in a location where MWA is technically achievable and safe based on the proximity to adjacent structures. Protective maneuvers such as hydrodissection for organ mobilization are allowed and will be recorded. 8. ECOG performance status of 0-1. 9. Platelet count \>50,000/mm3 (correctable allowed) within 30 days prior to study treatment. Exclusion Criteria: 1. Patient is unable to lie flat or has respiratory distress at rest. 2. Patient has uncontrolled and uncorrectable coagulopathy or bleeding disorders. 3. Patient has a history of an allergic reaction to intravenous iodine that cannot be pre-medicated or prevents performance of a CT with IV contrast. 4. Patient has evidence of active systemic infection. 5. Patient has a debilitating medical or psychiatric illness that would preclude giving informed consent or receiving optimal treatment or follow up. 6. Patient is currently participating in other experimental studies that could affect the primary endpoint. 7. Patient unable to receive general anesthesia or adequate analgesia and sedation. 8. Tumor location less than 25 mm from hilum (see diagrams with illustration of central ducts). 9. Patient is currently pregnant or intends to become pregnant
๐Ÿ’Š

What it tests

  • Microwave ablation
๐Ÿ“

Where

7 sites
Miami Cancer Institute
Miami, United States
Mayo Clinic
Rochester, United States
Memorial Sloan Kettering Cancer Center
New York, United States
MD Anderson Cancer Center
Houston, United States
Medical College of WI
Milwaukee, United States
National and Kapodistrian University of Athens (NKUA)
Athens, Greece
Amsterdam UMC
Amsterdam, Netherlands
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy